NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
6.78
-0.20 (-2.87%)
At close: Jul 16, 2026, 4:00 PM EDT
6.78
0.00 (0.00%)
After-hours: Jul 16, 2026, 6:30 PM EDT
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $83.97 million as of July 16, 2026. Its market cap has increased by 258.28% in one year.
Market Cap
83.97M
Enterprise Value
77.24M
1-Year Change
258.28%
Ranking
Category
Stock Price
$6.78
ChartMarket Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $83.97M, an increase of 357.04%. That is a compound annual growth rate of 67.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 83.97M | 73.61% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adicet Bio | 92.72M |
| Alterity Therapeutics | 91.20M |
| Acrivon Therapeutics | 91.17M |
| Cognition Therapeutics | 90.39M |
| Cardiff Oncology | 89.56M |
| LeonaBio | 89.43M |
| Pelthos Therapeutics | 88.28M |
| MAIA Biotechnology | 87.55M |